Navigation Links
Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
Date:6/22/2013

re financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans" and similar expressions. Although Sanofi's management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the absence of guarantee that the product candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, the Group's ability to benefit from external growth opportunities, trends in exchange rates and prevailing interest rates, the impact of cost containment policies and subsequent changes thereto, the average number of shares outstanding as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi's annual report on Form 20-F for the year ended December 31, 2
'/>"/>
SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
2. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
3. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
4. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
5. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
6. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
7. NextBio Announces Translational Medicine Partnership with Sanofi
8. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
9. Sanofi US Offers a New Way to Say "Thank You" and Recognize the Unsung Heroes of Severe Allergy Awareness
10. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015  The quality function within the ... products meet quality standards at every stage of the ... quality leaders also have the challenge of balancing quality ... Those who don,t effectively balance these priorities risk funding ... marketplace failure and regulatory scrutiny. For the ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 ... of Ohr Pharmaceutical, Inc. (NASDAQ: OHRP ) concerning ... certain statements issued by the Company in connection with ... information, GO TO: http://zlk.9nl.com/ohr-pharmaceutical-ohrp or contact ... jlevi@zlk.com or by telephone at (212) 363-7500, ...
(Date:3/27/2015)... - Medicure Inc. (the "Company") (TSXV:MPH, OTCQB:MCUJF) announces today ... of an aggregate of 236,070 options to certain directors, ... Company pursuant to the Company,s Stock Option Plan. Of ... tenth anniversary of the date of grant, 5,000 are ... date of grant and 50,000 are set to expire ...
Breaking Medicine Technology:New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2
... March 17 Kendle (Nasdaq: KNDL ), a leading, ... , Vice President, Asia/Pacific will address the World Pharma ... at the Raffles City Convention Centre in Singapore . Dr. ... scheduled for March 18 at 2 p.m. ...
... announced that it has received approval from the U.S. Food & Drug Administration to market Alprazolam orally disintegrating tablets. Distribution of the product will commence immediately.   , ... , ... ... ...
Cached Medicine Technology:Kendle Executive to Share Insights at World Pharma Trials Asia 2010 2Kendle Executive to Share Insights at World Pharma Trials Asia 2010 3Actavis Receives Approval of Alprazolam ODT in the U.S. 2Actavis Receives Approval of Alprazolam ODT in the U.S. 3
(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as part ... the latest and coolest applications on the market for ... NewsWatch and technology expert, conducted the app review and ... runner game with knights, nature, and peasants. , ... according to Eurogamer. The popularity of these games grew ...
(Date:3/28/2015)... The California-based leading wig brand UniWigs ... shopping on UniWigs during the Easter Holidays from today ... promotion on April Fools’ Day. , As the winter ... the corner. Easter Festival, with religious origins to countries ... holiday after Christmas. The best wig provider, UniWigs, would ...
(Date:3/28/2015)... Centurion Service Group will be hosting a live on-site and ... Las Vegas warehouse, located at 4606 Andrews St. Suite 3, ... equipment from hospitals and surgery centers from around the United ... Buyers will find items of all types including anesthesia, endoscopy, ... Erik Tivin, CEO of Centurion. , Among the sale’s ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... may not be necessary, according to research presented today ... AOSSM ) Specialty Day. , “Our study compared results ... 25 who underwent an additional glenohumeral joint capsule release ... commented George Murrell MD, PhD, lead author from St. ...
(Date:3/28/2015)... 28, 2015 Lately the student-athlete ... recent changes and proposals around the NCAA. In a ... former collegiate student-athletes across a spectrum of universities and ... common challenges. The special panel consists of athletes who ... ranging from football, track and field, baseball, and volleyball. ...
Breaking Medicine News(10 mins):Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3
... Control and Prevention (China CDC) and Fred Hutchinson Cancer ... a collaboration agreement. It marks the first such agreement ... center. The agreement a memorandum of understanding ... that support and contribute to the prevention, early detection, ...
... Reporter , THURSDAY, Oct. 28 (HealthDay News) -- A new ... appears to be more accurate than current noninvasive tests such ... The search for a highly accurate, noninvasive alternative to invasive ... of colon cancer research. In a preliminary trial, the ...
... , THURSDAY, Oct. 28 (HealthDay News) -- The H1N1 flu ... of children with a serious bacterial infection called empyema, a ... tissues surrounding the lungs, frequently requires a chest tube or ... often occurs as a complication of pneumonia. Researchers studied ...
... , THURSDAY, Oct. 28 (HealthDay News) Early humans ... years ago in Africa, more than 50,000 years earlier than ... evidence that modern behavior developed over time during the Middle ... to Europe, as some scientists have thought. Researchers from ...
... nervous system turn Neuroimmunology into one of the most ... 30th takes place in Sitges (Barcelona, Spain) the X ... Neuroimmunology. This event highlights the advances that have been ... also highlights the long road ahead. New biomarkers, potential ...
... reassigned to different prescription drug plans because Part D ... than the actual costs incurred, according to a study ... report describes how a system designed to encourage competition ... has led companies to raise their premiums in an ...
Cached Medicine News:Health News:Hutchinson Center and China CDC sign agreement for research and training collaboration 2Health News:Noninvasive Test for Colon Cancer Shows Promise in Early Trial 2Health News:Noninvasive Test for Colon Cancer Shows Promise in Early Trial 3Health News:Noninvasive Test for Colon Cancer Shows Promise in Early Trial 4Health News:H1N1 Flu Linked to Surge in Pneumonia Complication 2Health News:Early Humans More Advanced Than Thought 2Health News:Multiple sclerosis will become a controlled disease like AIDS 2Health News:Study identifies flaws in Medicare prescription drug program 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: